These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32695829)

  • 1. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
    J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of blink reflex R1 latency as an electrophysiological marker in diabetic distal symmetrical polyneuropathy.
    Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
    Clin Neurophysiol; 2020 Jan; 131(1):34-39. PubMed ID: 31751837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of clinical alternatives to nerve conduction studies for screening for diabetic distal symmetrical polyneuropathy: A multi-center study.
    Zhao Z; Ji L; Zheng L; Yang L; Yuan H; Chen L; Shan Z; Shen S; Li Q; Shi B; Liu Y; Ji Q; Bao Y; Gao X; Xie Y; Liu Y; Chen L; Han X; Wu F; Yang C; Du J; Gao Y; Zou D
    Diabetes Res Clin Pract; 2016 May; 115():150-6. PubMed ID: 27116903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
    Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
    Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.
    Raputova J; Srotova I; Vlckova E; Sommer C; Üçeyler N; Birklein F; Rittner HL; Rebhorn C; Adamova B; Kovalova I; Kralickova Nekvapilova E; Forer L; Belobradkova J; Olsovsky J; Weber P; Dusek L; Jarkovsky J; Bednarik J
    Pain; 2017 Dec; 158(12):2340-2353. PubMed ID: 28858986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERFORMANCE OF TWO DIFFERENT CLINICAL SCORING SYSTEMS IN DIAGNOSING DISTAL SENSORY POLYNEUROPATHY IN PATIENTS WITH TYPE-2 DIABETES.
    Khan FF; Numan A; Khawaja KI; Atif A; Fatima A; Masud F
    J Ayub Med Coll Abbottabad; 2015; 27(1):187-91. PubMed ID: 26182773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close relationship between cardiovagal function and sural sensory nerve action potential in type 2 diabetes.
    Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
    Clin Neurophysiol; 2019 Jul; 130(7):1160-1165. PubMed ID: 31102989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
    Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
    Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyneuropathy in type 1 and type 2 diabetes: comparison of nerve conduction studies, thermal perception thresholds and intraepidermal nerve fibre densities.
    Løseth S; Mellgren SI; Jorde R; Lindal S; Stålberg E
    Diabetes Metab Res Rev; 2010 Feb; 26(2):100-6. PubMed ID: 19943330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus.
    Gómez-Banoy N; Cuevas V; Soler F; Pineda MF; Mockus I
    Arch Endocrinol Metab; 2017; 61(5):470-475. PubMed ID: 28724059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy.
    Xiong Q; Lu B; Ye HY; Liu SY; Zheng HP; Zhang RY; Qiao XN; Zhang S; Liu XX; Li QC; Yi N; Wu LC; Wen J; Zhang TS; Li YM
    Diabetes Res Clin Pract; 2018 Feb; 136():85-92. PubMed ID: 29221815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes.
    Lai YR; Chiu WC; Huang CC; Cheng BC; Kung CT; Lin TY; Chiang HC; Tsai CJ; Kung CF; Lu CH
    Neurophysiol Clin; 2024 Jul; 54(4):102982. PubMed ID: 38761793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™).
    Hirayasu K; Sasaki H; Kishimoto S; Kurisu S; Noda K; Ogawa K; Tanaka H; Sakakibara Y; Matsuno S; Furuta H; Arita M; Naka K; Nanjo K
    J Diabetes Investig; 2018 Sep; 9(5):1173-1181. PubMed ID: 29430866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
    Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
    Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.